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Abstract
Serum and glucocorticoid inducible kinase 1 (SGK1) plays a pivotal role in early angiogenesis during embryonic
development. In this study, we sought to define the SGK1 downstream signalling pathways in the adult heart and to
elucidate  their  role  in  cardiac  neo-angiogenesis  and  wound  healing  after  myocardial  ischemia.  To  this  end,  we
employed a viable SGK1 knockout mouse model generated in a 129/SvJ background. Ablation of SGK1 in these
mice  caused  a  significant  decrease  in  phosphorylation  of  SGK1  target  protein  NDRG1,  which  correlated  with
alterations  in  NF-κB  signalling  and  expression  of  its  downstream  target  protein,  VEGF-A.  Disruption  of  these
signalling pathways was accompanied by smaller heart and body size. Moreover, the lack of SGK1 led to defective
endothelial cell (ECs) migration and tube formation in vitro, and increased scarring with decreased angiogenesis in
vivo after myocardial infarct. This study underscores the importance of SGK1 signalling in cardiac neo-angiogenesis
and wound healing after an ischemic insult in vivo.
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Introduction
Neo-angiogenesis,  the  process  of  new  blood  vessel
formation  from  the  pre-existing  network  of  capillaries,  is  a
response  to  many  physiological  and  pathological  conditions
such as myocardial ischemia, diabetes and cancer [1,2]. In the
heart, activation of neo-angiogenesis around the ischemic area
helps to supply oxygen and nutrients thereby decreasing cell
death and scar formation [1,2]. During embryonic development,
serum and glucocorticoid inducible kinase 1 (SGK1) is reported
to be an important player in early angiogenesis [3]. SGK1 is a
serine-threonine protein kinase first cloned from rat mammary
tumours  in  response  to  glucocorticoid  stimulation  [4].  SGK1
belongs  to  the  AGC  kinase  subfamily,  acting  downstream  of
insulin  and  growth  signalling  pathways  in  response  to
phosphorylation  by  PIP3-dependent  protein  kinase-1  (PDK1)
[5]. Two additional distinct SGK isoforms have been identified
(SGK2  and  SGK3).  All  SGK  isoforms  share  similar  target
specificities  with  other  AGC  family  members  such  as  Akt
(PKB), RSK, and S6K [6].
N-Myc  downstream  regulated  gene-1  (NDRG1,  Cap  43,
Drg1)  is  the  specific  physiological  substrate  for  SGK1  [7].
NDRG1 expression is regulated by oncogenes (N-myc and C-
myc) and tumour suppressors (p53, VHL, and PTEN) [8]. Over-
expression  of  NDRG1  has  been  shown  to  suppress  tumour
growth  through  modification  of  angiogenesis  [9].  Both  over-
expression  and  phosphorylation  of  NDRG1  by  SGK1  have
been  reported  to  inhibit  the  nuclear  factor  kappa  B  (NF-κB)
pathway and decrease expression of angiogenic genes such
as CXC chemokines and vascular endothelial growth factor-A
(VEGF-A) [9,10].
PLOS ONE | www.plosone.org 1 November 2013 | Volume 8 | Issue 11 | e80268In previous analyses, we found that SGK1-/- mice, generated
as 129/SvJ background are viable with no significant cardiac
phenotype [11]. Nevertheless, when backcrossed for more than
five  generations  in  C57BL/6  background  they  showed
embryonic  lethality  due  to  an  early  cardiovascular  defect  at
E10.5-E11.5 [3]. Based on these data, we investigated the role
of  SGK1  and  NDRG1  phosphorylation  in  cardiac  neo-
angiogenesis and wound healing in adult SGK1 null mice on a
129/SvJ  mouse  background.  We  show  that  inactivation  of
SGK1 caused a dramatic decrease in NDRG1 phosphorylation
in  the  heart  and  endothelial  cells  (ECs).  NDRG1  modulation
was associated with degradation of NF-κB inhibitory proteins
and  increased  in  VEGF-A  protein  expression.  This  disrupted
signalling  resulted  in  defective  migratory  and  in  vitro  tube
formation capacity of SGK1-/- ECs compared to wild-type (WT)
ECs. Importantly, in vivo analyses showed that SGK1 deletion
worsened scar formation a month after coronary artery ligation
due to lower density of vessels per cardiomyocyte around the
scar area compared to WT mice. Our results elucidate the role
of SGK1 signalling in the regulation of angiogenesis and wound
healing in the adult heart, an effect involving phosphorylation of
its downstream substrate NDRG1.
Materials and Methods
Mice
All animal studies and breeding protocols were performed in
compliance  with  international  (Directive  2010/63/EU  of  the
European  Parliament)  and  national  (UK  Home  Office,  Act
1986) regulations. Imperial College board Committee granted
internal ethical approval. All animals were examined daily for
development  of  any  adverse  signs  and  symptoms  indicating
pain,  distress  or  discomfort.  Any  animal  giving  cause  for
concern  was  weighed  and  monitored  and  if  there  was  body
weight  loss  of  more  than  20%  and/or  significantly  laboured
breathing as well as the following clinical signs: piloerection,
hunched  posture,  reduced  mobility,  pallor,  ocular  or  nasal
discharge, diarrhoea was humanely culled as described below.
In all experimental procedures mice were anaesthetised with
inhaled Isoflurane (1.5-2.5%) and 1.5 ml/min O2. Adequacy of
anaesthesia was monitored by foot pinch before incision. For
tissue  extraction  and  primary  cell  isolation,  mice  were
euthanized by cervical dislocation after being anesthetised with
4% Isoflurane (National Veterinary Services, NVS, UK). After
surgery, animals were allowed to recover with free access to
food and water. Injection of analgesia (e.g. buprenorphine) was
performed  as  required  post-operatively.  SGK1-/-  mice  were
genotyped as previously described [11]. Male mice were used
for physiological studies and isolation of cardiomyocytes and
female mice were used for isolation of ECs.
Materials
Antibodies:  pan  SGK  (≠3272),  SGK2  (≠5595),  SGK3
(≠8156),  p-NDRG1-Thr346  (≠5482),  NF-κB2/p100  (≠4882),
GAPDH  (≠2118)  were  purchased  from  Cell  Signalling;  total
NDRG1 from university of Dundee (DSTT); VEGF-A (≠sc-507),
and  inhibitor  of  kappa-B  alpha  (IκBα)  (≠sc-56710)  antibody
from Santacruz; Isolectin beta-4 (ILB4) (≠L2140) and Wheat-
germ agglutinin (WGA) (≠L4895) from Sigma; Matrigel from BD
Biosciences (≠734-0269); Proliferation kit from Roche (≠11 810
740  001);  CytoSelect  migration  assay  (≠CBA-106)  from  Cell
Biolab and di-8-ANEPPS from Molecular Probes.
Echocardiography
2-3 month old WT and SGK1-/- mice were analysed under
anaesthesia (2.5% Isoflurane, 1.5 ml/min O2). Short-axis view
trans-thoracic  echocardiography  (ECHO)  was  performed  on
shaved  mice  at  the  height  of  the  papillary  muscles.  The
operator was blinded at the time of measurement to genotype
of  each  mouse  analysed.  Ejection  fraction  (%EF)  was
determined  in  2D  and  M-mode,  fractional  shortening  (%FS)
was measured in M-mode by a Sonos 5500 (Philips) equipped
with a 15MHz transducer.
Coronary artery ligation
Left coronary artery ligation was performed on 3 month old
mice  as  previously  described  [12].  In  brief,  mice  were
anaesthetized with 1.5% Isoflurane and the chest cavity was
opened  in  the  left  fourth  intercostal  space.  The  heart  was
exposed and the left anterior descending coronary artery (LAD)
was ligated with an 8.0 non-absorbable suture (Ethicon) below
the left atrium to produce an infarct size of about 40%. Mice
were  sacrificed  one  month  after  ligation  and  samples  were
collected for immunohistochemistry, protein and RNA analysis.
Immunohistological analysis
Hearts  were  harvested,  washed  in  PBS  and  fixed  in  4%
paraformaldehyde.  The  fixed  heart  samples  were  then
embedded in paraffin and 5 µm microtome sections were used
for different staining after being deparaffinised and boiled for 10
minutes in 10 mM sodium citrate (pH=6). Microvessels were
stained with endothelial cell marker ILB4 (Biotinylated) at a 100
fold dilution and cardiomyocytes were stained with the marker
Wheat-germ  agglutinin  (WGA),  FITC  conjugated,  at  a
concentration  of  5µg/ml.  Microvessels  and  cardiomyocytes
were counted in 10 defined microscope fields. To quantify the
scar  area  after  coronary  artery  ligation,  heart  sections  were
stained  with  picro-sirius  red  for  collagen  deposition.  Three
different sections at the start, mid and the end of scar were
used for staining and the percentage of scar size was reported
as the mean value of epicardial and endocardial scar in each
section using NIS-element AR3.0 software.
Immunoblotting
Western  blot  analysis  performed  on  tissue  and/or  cell
extracts as previously described [13]. In brief 40-50µg protein
samples were loaded to SDS-gel followed by electrotransfer to
a nitrocellulose membrane. Primary antibodies were applied at
a 1000 fold dilution for commercial antibodies and of 0.1 µg/ml
concentration  for  Total  NDRG1  (Dundee)  in  TBS/Tween
overnight  at  4°C.  Protein  detection  was  performed  using
horseradish peroxidase conjugated secondary antibodies and
the enhanced chemiluminescence reagent.
Bands  were  quantified  with  ImageJ,  a  Java-based  image
analysis  package  widely  used  for  measurement  of  density
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the band, INT) or volume (average OD of the band times its
area, INT*mm2) of the band of the expected molecular weight.
Briefly, after scanning the western blot films, the images were
saved as jpg format. After opening the image in the Image J
program,  the  area  around  each  band  was  specified  by
rectangular selection in the program tools. The program then
plots  the  same  rectangular  around  all  the  other  bands  and
quantifies  the  intensity  of  each  band.  The  intensity  of  each
band was then normalised with the intensity of corresponding
loading controls.
Real Time PCR
Total RNA was extracted and quantitative real-time reverse-
transcribed  polymerase  chain  reaction  was  performed  as
described  previously  [14]  with  off-the-shelf  Taqman  probes
(Applied Biosystems). Analysis was performed with the ΔΔCt
method with an 18S probe for normalization.
Primary cell preparation
Cardiomyocytes were isolated from 2-3 month old male mice
after  standard  enzymatic  digestion  as  previously  described
[15].  Cardiomyocytes  were  then  stained  with  the  membrane
binding dye di-8-ANEPPS (10µM) for 10 minutes in the dark.
Confocal image stacks were obtained using the Zeiss LSM 510
microscope with 40x objective lens using Argon 488 laser. The
images were analysed to calculate cell volume as previously
described [16].
ECs were isolated from 2-3 month old mice. After euthanasia
hearts  were  excised  and  minced  in  cold  PBS.  Single  cell
isolation was achieved after digestion of hearts in collagenase
IV  (Roche)  for  one  hour  at  37°C.  Cell  debris  was  discarded
through  a  cell  strainer  (100µm)  and  cardiomyocytes  were
removed after first centrifugation at 20g. The remaining cells
were washed by centrifugation at 300g several times with PBS/
EDTA/BSA  buffer  (PEB  buffer)  containing  phosphate  buffer
saline (PBS) 1X, pH 7.2, 0.5% bovine serum albumin (BSA)
and  2  mM  EDTA.  Cells  were  then  labelled  with  EC  marker
CD146  (Miltenyi  Biotec  ≠130-092-007)  and  selected  through
magnetic cell separation (MACS) columns as recommended by
manufacture’s  experimental  procedure  (Milteny  Biotec,  Inc.).
ECs  were  cultured  in  DMEM  supplemented  with  10%  FCS,
endothelial cell growth factors (ECGS) (Sigma) and heparin in
1% fibronectin pre-coated culture dishes for 1 week.
EC proliferation analysis
ECs  were  cultured  on  chamber  slides  to  reach  50%
confluence. Proliferation of ECs was measured using In Situ
Cell proliferation kit (Roche) according to the manufacturer. In
brief  ECs  were  incubated  with  a  thymidine  analogue,  5-
bromo-2`-deoxyuridine (BrdU) at the concentration of 10 µM for
24h. At the end of the incubation time, cells were fixed with a
mixture of ethanol/glycine (50 mM, pH 2.0), washed with PBS
and  stained  with  anti-BrdU-FLUOS  antibody  for  45  minutes
followed by DAPI staining for 5 minutes. The number of BrdU
positive cells was evaluated by Zeiss fluorescent microscopy
and normalized by the total number of cell nuclei stained with
DAPI.
EC migration analysis
Primary  ECs  from  mice  heart  were  serum  starved  for  12h
and subsequently seeded at 1-2x104 cells per well in a serum-
free media into the upper chamber of CytoSelect™ 96-well cell
migration  (Cell  Biolabs)  covering  the  lower  chamber  with  a
polycarbonate membrane with a diameter of 8 µm. Cells were
allowed  to  migrate  toward  10%  FCS  for  24h.  The  migratory
cells on the bottom of the membrane were then detached and
quantified  using  CyQuant  GR  fluorescent  dye  at  480nm/520
nm wavelength using fluorescent plate reader as described by
manufacturer (Cell Biolab).
EC tube formation analysis
1-2x104  primary  ECs  were  seeded  on  Martigel  (BD
Biosciences)  coated  12  well  plate  culture  dishes.  Tube
formation was visualized at 10X magnification with Zeiss light
microscopy after 7 and 24h. In a subset of experiments, VEGF-
A  was  neutralized  by  adding  VEGF-A  antibody  (2ug/ml)  and
control rabbit IgG to the media as previously described [17].
Tube formation was quantified by tracing along the tubes using
NeuronJ  software  (an  ImageJ  plugin).  The  number  of  traces
per 8 bit jpeg images was quantified from 10 different culture
dishes. The significance of the results was assessed using a
Student-t test.
Kinexus Proteomic Analysis
Three WT and SGK1-/- hearts were lysed in non-denaturing
buffer  purchased  from  Kinexus  Bioinformatics  Corporation
(Vancouver, Canada). Samples were delivered to Kinexus in
dry  ice  and  subsequently  labelled  with  fluorescent  dye.
Labelled  samples  were  run  on  a  KinexTM  850-KAM  antibody
microarray  chip  containing  850  different  antibodies.  Detected
fluorescent  samples  were  quantified  and  the  differences
between WT and KO analysed as Z-ratio (KO/WT fluorescent
intensity).
Adenovirus infection
Three  months  old  WT  and  KO  mice  were  used  to  extract
endothelial  cells  as  described  above.  Isolated  cells  were
maintained in DMEM supplemented with 10% FCS, endothelial
cell  growth  factors  (ECGS)  (Sigma)  and  heparin  in  1%
fibronectin  pre-coated  culture  dishes  for  1  week.  Cells  were
then trypsinized and plated 50-60% confluency in EC media for
12  hours,  prior  infection  with  an  adenovirus  expressing  the
constitutively  active  form  of  SGK1  and  a  control  adenovirus
expressing beta-Galactosidase (βGal) [18]. Cells were infected
for 12 hours in DMEM containing 10% FBS followed by plating
on matrigel coated dishes as described above. Tube formation
was assessed 7 hours after plating.
Statistical analysis
GraphPad Prism (version 5) was used to perform statistical
analysis. Student t -test analysis was performed for normally
distributed  data.  ANOVA  was  used  as  indicated  in  Figure
legends. Results were presented as the average± SE. *p<0.05,
**p<0.01, ***p<0.001
SGK1 in Cardiac Angiogenesis
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SGK1-/- mice display a cardiac phenotype
Generation of SGK1-/- mice has been described previously
[11].  In  brief,  exons  4-11,  which  encode  the  SGK1  kinase
domain, were constitutively deleted in the germ line using Cre-
lox technology. The mice were fertile and showed no significant
phenotype  apart  from  their  smaller  body  weight  and  heart
weight  (Table  1).  Echocardiography  analyses  revealed  that
cardiac systolic and diastolic functions defined by %EF, %FS
and E/A ratio respectively were comparable between WT and
SGK1-/- mice. However, a significantly slower heart rate was
observed in SGK1-/- mice (Table 1).
Decreased  heart  weight  observed  in  SGK1-/-  was
accompanied  by  reduced  cardiomyocyte  size  evaluated  by
cross-sectional area in WGA stained heart sections (Figure 1A)
and by cell volume measured in isolated adult cardiomyocytes
(Figure 1B).
Reduced NDRG1 phosphorylation in SGK1-/- hearts
To  investigate  the  effectiveness  of  SGK1  deletion,  heart
samples from WT and SGK1-/- mice were analysed for SGK
protein expression by Western blotting. As shown in Figure 2A,
the  pan  SGK  antibody  recognizes  different  SGK  isoforms.
However,  the  expression  of  the  middle  band  at  54  KDa
corresponding  to  SGK1  isoform  was  abolished  in  SGK1-/-
mice.  To  further  investigate  the  ablation  of  SGK1  in  these
animals, the phosphorylation state of NDRG1, a downstream
target  of  SGK1  was  examined.  NDRG1  is  specifically
phosphorylated  by  SGK1  at  residue  threonine-346  [7].
Correspondingly, Western blot analysis of SGK1-/- whole heart
samples  showed  a  significant  decrease  in  NDRG-1
phosphorylation  at  threonine-346  (Figure  2A).  Decreased
Table 1. Cardiac phenotype of SGK1-/- mice.
  WT SGK1-/-
Morphologic: (n=8) (n=7)
HW (mg) 190±3 120±5*
HW/BW 5.5±0.1 5.1±0.2
BW (g) 34±1 23.4±0.9*
Echocardiographic: (n=8) (n=7)
LVEDD (mm) 4.33±0.0 4.17±0.0
LVESD (mm) 2.91±0.1 2.64±0.1
EF% 67±3 72±2
FS% 33±2 36±1.6
HR 415±2 319±13**
E/A 1.5±0.2 1.7±0.14
Mice  were  weighed  at  8  weeks  and  dissected  wet  heart  weight  measured.  2-3
month old male mice were used for functional analysis of the heart by measuring
the  percentage  of  ejection  fraction  (%EF)  and  fractional  shortening  (%FS).  n,
number of mice, BW, body weight, HW, heart weight; HW/BW, ratio of HW to BW;
LVEDD, left ventricular end diastolic diameter; LVESD, left ventricular end systolic
diameter; HR, heart rate. E/A, maximal speed of early to late mitral filling ratio.
Student t-test has been used to calculate significance and * p<0.05; **p<0.01.
doi: 10.1371/journal.pone.0080268.t001
NDRG-1 phosphorylation was also observed in primary ECs,
adult  cardiomyocytes  and  fibroblasts  isolated  from  SGK1-/-
mice (Figure 2B and 2C). Importantly, the expression levels of
the other isoforms SGK2 and SGK3 in the heart assessed by
western blot did not show any significant difference between
WT  and  SGK1-/-  mice,  ruling  out  any  compensatory
modifications in the level of these isoforms (Figure S1).
Modification of NF-κB pathway in SGK1-/- hearts
To investigate NF-κB signalling, which is downstream of the
SGK1/NDRG1 pathway, Western blot analysis was performed
on  WT  and  SGK1-/-  heart  samples  for  two  well-known
inhibitory  components  of  NF-κB  pathways:  IκBα  in  the
canonical and NF-κB2/p100 in the non-canonical pathway [19].
The  expression  level  of  VEGF-A  was  also  assessed  by
Western  blot  as  a  transcriptional  target  of  NF-κB  [20].  As
shown  in  Figures  3A  and  3B,  expression  of  both  inhibitory
proteins,  IκBα  and  NF-κB2/p100,  was  downregulated  in
SGK1-/-  heart  samples.  Decreases  in  these  inhibitory
components were accompanied by a significant increase in all
VEGF-A  isoforms  (25,  20  and  15  KDa)  in  SGK1-/-  heart
samples (Figure 3C). Furthermore, extracts from cardiac cell
types showed that endothelial cells are the main producers of
VEGF  in  SGK1  KO  hearts  compared  to  cardiomyocytes,
secreting similar levels of this factor (Figure S2A and S2B).
Proteomic profile of SGK1-/- hearts
To  investigate  whether  deletion  of  SGK1  was  involved  in
regulating other downstream targets, we performed proteomic
analyses  by  assessing  the  expression  and  phosphrylation
profile  of  850  different  proteins  using  a  Kinexus  antibody
microchip array (Figure S3). Our data showed that depletion of
SGK1  is  associated  with  differential  regulation  of  proteins
implicated in cell cycle initiation or progression such as Aurora
A (1.5+/-0.41 fold induction compared to WT heart) [21], PAC1,
regulator  of  mitotic  and  apoptotic  signalling  (3.6+/-1.9  fold
induction  compared  to  WT)  [22,23]  and  CDK7  activator  of
transcription [24] (-4.7+/-2.7 fold reduction compared to WT).
Interestingly, Btk, known to activate NFkB [25,26], is induced a
1.4+/-0.3  fold  in  SGK1-/-  hearts  compared  to  WT,  further
corroborating the data presented in this manuscript.
Defective tube formation in SGK1-/- ECs
The role of SGK1 in EC tube formation was examined by
culturing primary ECs isolated from WT and SGK1-/- mice on
Matrigel-coated  culture  dishes.  As  shown  in  Figure  4A,  ECs
isolated from SGK1-/- mice formed fewer tube networks after 7
and 24 h, compared to WT cells. Importantly, re-expression of
SGK1  by  infection  of  ECs  with  an  adenovirus  encoding  the
constitutively active form of SGK1 (Figure S4A and S4C) re-
established tube networks compared to KO ECs infected with
control virus expressing βGal (Figure S4B).
To investigate whether this phenotype was due to a defect in
proliferative capacity of SGK1-/- ECs, we incubated the ECs
with a thymidine analogue, 5-bromo-2`-deoxyuridine (BrdU) for
24h. Figure 4B presents the ratio of BrdU incorporated cells per
total  amount  of  cells  stained  with  DAPI.  No  significant
differences  were  observed  between  WT  and  SGK1-/-  ECs,
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lower tube formation. Assessment of ECs migratory capacity
showed  a  significantly  higher  migration  level  in  ECs  isolated
from WT than from SGK1-/- hearts (Figure 4C), indicating that
SGK1 signalling supports ECs migration. We further analysed
the  effect  of  VEGF-A  on  ECs  tube  formation  by  neutralizing
VEGF-A in the media. Our results demonstrated that blocking
VEGF-A partially improved SGK1-/- ECs capacity to form tubes
(Figure  S2C).  To  analyse  whether  ECs  contribute  to  the
signalling observed in the hearts, expression of NFκB inhibitory
proteins was measured by western blot analysis. In Figure 4D,
it is shown that IκBα expression in the canonical pathway is
downregulated, although no differences were found in NF-κB2/
p100  expression  levels  (communication  from  the  authors).
These data suggest that the canonical pathway of NFκB is in
part regulating EC function.
Modulation of SGK1 signalling in SGK1-/- hearts in
response to myocardial ischemia
To  investigate  the  impact  of  defective  SGK1  activity  on
cardiac recovery after ischemic insult, mice were subjected to
left  anterior  descending  coronary  artery  ligation  (LAD).
Assessment of SGK1 downstream pathways was performed by
western blot analysis one month after coronary artery ligation
to  explore  whether  ischemic  insult  modulated  the  signalling
observed  in  physiological  conditions  (Figure  5).  NDRG1
phosphorylation  decreased  in  SGK1-/-hearts  a  month  after
infarction (Figure 5A). This was accompanied by decreases in
IκBα  and  NFκB2/p100  protein  expression  (Figure  5B)  and
increases  in  expression  of  all  VEGF-A  isoforms  (Figure  5C).
Thus,  in  pathological  conditions,  SGK1  ablation  modulates
similarly  the  signalling  pathways  observed  in  physiological
conditions.
Figure 1.  Lack of SGK1 correlated with reduced cardiomyocyte size.  (A) Cross sectional area in heart sections from WT and
SGK1-/- mice. Area was measured in ≥10 distinct microscope field for each slide. Four hearts were analysed for each slide in both
WT and SGK1-/- mice. Scale bar represents 50 µm. (B) Confocal images of isolated adult cardiomyocytes form WT and SGK1-/-
mice The data represent the average of three independent experiments and are reported as Mean ± SE. Cell volume was measured
using  a  custom-written  macro  in  ImageJ.  Scale  bars  represent  5µm.  Statistical  analysis  has  been  performed  as  described  in
Materials and Methods using Student t-test; *** indicates p<0.001.
doi: 10.1371/journal.pone.0080268.g001
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with defective capillary formation after coronary artery
ligation
Cardiac fibrosis was evaluated one month after myocardial
ischemia in SGK1-/- and WT mice by histochemical analysis
and collagen3a (Col3a) gene expression (Figure 6 A and B).
Specifically,  the  expression  level  of  Col3a  was  significantly
increased  after  myocardial  ischemia  and  was  further
upregulated in SGK1-/- mice (Figure 6A). Consistent with this
genetic profile, immunohistochemical analysis of heart sections
using  the  collagen  marker  Sirius  red  showed  an  increased
collagen deposition and scar size in SGK1-/- mice (Figure 6B).
To  investigate  the  potential  impact  of  defective  ECs  on
cardiac  recovery  and  neo-angiogenesis  after  ischemic  insult,
mice  were  analysed  for  vessel  density.  Isolectin  B4  did  not
stain  large  vessels  (Figure  S5A)  and  was  used  to  mark  the
microvasculature of WT and SGK1-/- hearts (Figure S5A and
S5B). Vessel density was measured in heart sections before
and  after  myocardial  infarct  (Figure  7  A  and  B)  and  was
reported as number of ILB4-positive vessels per cardiomyocyte
(Figure 7 C) and per mm2 (Figure 7D). No significant difference
was  observed  between  WT  and  SGK1-/-  capillary  density
before  myocardial  ischemia  (Figure  7A,  C  and  D),  however,
one month after LAD the amount of capillary per cardiomyocyte
and capillary per mm2 around the scar area was significantly
lower in SGK1-/- hearts (Figure 7B, C and D). Measurements
of cardiomyocyte cross-sectional area (Figure 7E) showed no
significant  differences  between  WT  and  SGK1-/-
cardiomyocytes 1 month after myocardial infarct induction. The
data  suggests  that  decreased  vessel  formation  may  lead  to
Figure 2.  Downregulation of NDRG1 phosphorylation in SGK1-/- hearts.  Western blot analysis of SGK, phospho-NDRG1 and
total NDRG1 in the heart (A), primary endothelial cells (ECs), adult cardiomyocytes (CMC) and fibroblasts (Fibro) from WT and
SGK1-/- mice (B). Quantification of band intensities was performed using ImageJ. The number of hearts analysed was ≥4 in each
group (C). Significance has been measured by Student t-test has described in Materials and Methods and *** indicates p<0.001, **
p<0.01 and * p<0.05. The data are reported as Mean ± SE.
doi: 10.1371/journal.pone.0080268.g002
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cell death at specific time points after infarction.
Discussion
The  present  study  highlights  a  novel  and  pivotal  role  for
SGK1  in  adult  cardiac  repair  after  ischemic  insult  through
promotion of neo-angiogenesis around the scar area. Analysis
of the intracellular signalling pathways involved in SGK1 action
revealed impaired NDRG1 phosphorylation in the heart, as well
as in primary ECs, cardiomyocytes and fibroblasts of SGK1-/-
mice. NDRG1 has been described as an important player in
angiogenesis in different cell systems [27], although its role in
cardiac tissue has not been explored in any detail. Indeed, both
over-expression  and  phosphorylation  of  NDRG1  modified
angiogenic gene expression in pancreatic cancer cells through
down-regulation of the NF-κB pathway [9,10].
Here  we  demonstrated  that  decreased  NDRG1
phosphorylation in SGK1-/- hearts was accompanied by down
regulation of two NF-κB inhibitory components: IκBα and NF-
κB2/p100 proteins. The NF-κB family consists of five members:
NF-κB1 (p105/p50), NF-κB2 (p100/p52), RelA (p65), RelB and
c-Rel [19]. In most cell types, the NF-κB complex is retained in
the  cytoplasm  by  inhibitors  of  κB  proteins  (IκBs).  The  C-
terminal  part  of  NFkB2/p100  also  functions  as  an  inhibitor,
retaining the NF-κB complex in the cytoplasm [19]. IκBα and
NF-κB2/p100  degradation  leads  to  release  of  NF-κB  DNA-
binding proteins (p50 and p52) to the nucleus and results in
transcription of its target genes [19]. To corroborate our data,
proteomic analysis showed upregulation of the NF-κB activator
Btk [25,26] in SGK1-/- hearts. These results indicate elevated
Figure 3.  Modulation of NF-κB pathway and VEGF-A expression by SGK1.  Western blot analysis of IκBα (A), NF-κB2/p100 (B)
and VEGF-A (C) in WT and SGK1-/- hearts. GAPDH and α-Tubulin were used as loading controls. Quantification of band intensities
for each represented blot was performed using ImageJ. The number of hearts analysed was ≥4 in each group and statistical
analysis is performed by Student t-test. ** Indicates p<0.01, *** p<0.001. The data are reported as Mean ± SE.
doi: 10.1371/journal.pone.0080268.g003
SGK1 in Cardiac Angiogenesis
PLOS ONE | www.plosone.org 7 November 2013 | Volume 8 | Issue 11 | e80268NF-κB  pathway  activity  in  the  heart  in  response  to  SGK1
ablation.
Downregulation  of  both  IκBα  and  NF-κB2/p100  in  SGK1-/-
hearts was accompanied by higher levels of VEGF-A, an NF-
κB  target  protein  in  both  physiological  and  pathological
conditions.
VEGF-A is a key regulatory component of physiological and
pathological angiogenesis [28]. Notably, both under- and over-
expression of VEGF-A disrupt normal development and vessel
formation:  deletion  of  VEGF-A  caused  embryonic  lethality  at
day E9.5 [29], whereas overexpression of VEGF-A up to 2-3
fold  resulted  in  severe  cardiac  development  abnormality  and
embryonic  lethality  at  day  E12.5-E14  [30].  Mutant  embryos
over-expressing VEGF-A displayed cardiac malformation and
aberrant coronary organization [30]. Similarly, in another study
performed in quail embryos, injection of VEGF-A at day E4.5
caused cardiovascular malformation, enlarged heart and thin-
walled  myocardium  [31].  Higher  VEGF-A  mRNA  expression
was  also  detected  in  SGK1-/-  embryos  at  day  E9.5  in  the
C57BL/6  mice  background,  which  may  in  part  explain  their
growth retardation, angiogenesis defect and embryonic lethality
at day E10.5-E11.5 [3]. Accordingly, the smaller size of adult
SGK1-/- mice in a 129/SvJ background can also be a result of
higher VEGF-A protein level. Nevertheless, as SGK1 is a target
of  growth  factor  signalling  pathways,  the  smaller  phenotype
could be a direct result of disrupted growth signalling in these
mice.  Indeed,  we  found  that  the  phosphorylation  level  of
ribosomal protein S6, implicated in protein synthesis signalling,
was  lowered  in  SGK1-/-  mice  (personal  communication  from
the authors).
Figure 4.  SGK1 affects EC phenotype.  Primary ECs from WT and SGK1-/- hearts were assessed for tube formation capacity
after culture on Matrigel for 7 and 24h. Tube ramification was quantified using Neuron J software. Scale bars represent 100 µm (A).
Proliferation capacity of ECs measured 24h after incubation with BrdU (B). Endothelial cell migration capacity was measured using
CytoSelect cell migration assay (C). NFkB signalling was measured by analysing the expression levels of the inhibitory protein IkBα.
Blots were normalized for GAPDH. Two representative experiments are shown. Four hearts were used in both WT and SGK1-/-
mice  and  statistical  analysis  has  been  performed  by  Student  t-test  as  described  in  Materials  and  Methods.  Ns  indicates  no
significant; * p<0.05, ***p<0.001. The data are reported as Mean ± SE.
doi: 10.1371/journal.pone.0080268.g004
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VEGF-A.  Primary  ECs  isolated  from  SGK1-/-  hearts  showed
defective cell migration and failed to form organized networks
when cultured on Matrigel. Importantly, re-expression of SGK1
by  infection  of  an  adenovirus  encoding  CA-SGK1  rescued
formation of tube networks. Perturbation in VEGF-A signalling
may explain the impaired behaviour of SGK1-/- ECs. Indeed,
neutralizing VEGF-A in the media partially improved SGK1-/-
EC tube formation capacity (Figure S2C) further implying a role
for VEGF-A in this process. Although VEGF-A is a major player
in angiogenesis, other signalling may contribute in synergy to
enhance  tissue  revascularization.  Angiogenesis  occurs  in
several  well  characterized  stages  including  degradation  of
vessel  basement  membrane,  liberation,  proliferation  and
migration of ECs to make appropriate connections [2], a defect
in any of these steps may result in impaired tube formation and
angiogenesis. Previous studies suggested a role for SGK1 and
NDRG1  in  cell  migration  through  modification  of  adhesion
molecules such as Vinculin and E-Cadherin [32], which may
account for the lower capacity of endothelial cell migration in
SGK1-/- mice leading to defective tube formation.
Defective ECs impaired also cardiac remodelling and neo-
angiogenesis in vivo, evident one month after coronary artery
ligation. At this time, expression levels of fibrotic marker Col3a
were  significantly  higher  in  SGK1-/-  hearts,  correlating  with
increased scar size and indicating an increase in the fibrotic
response.  Furthermore,  the  decrease  in  microvessel  density
around the scar area in SGK1-/- hearts clearly demonstrates a
beneficial  role  for  SGK1  in  neo-angiogenesis  and  wound
healing after myocardial ischemia.
It is important to emphasise that other pathological models
may lead to different outcome regarding the role of SGK1 in
fibrosis  and  cardiac  function.  Some  studies  showed  a
profibrotic  effect  of  SGK1  in  response  to  mineralocorticoid
Figure 5.  Disruption of SGK1 downstream signalling after coronary artery ligation.  Western blot analysis of NDRG1 (A),
IκBα, NF-κB2/p100 (B) and VEGF-A (C) of WT and SGK1-/- hearts after LAD. GAPDH and α-Tubulin were used as loading controls.
Quantification of band intensities was performed using ImageJ. The number of hearts analysed was ≥4 in each group. Significance
is calculated by Student t-test and * p<0.05, ** p<0.01, ***p<0.001. The data are reported as Mean ± SE.
doi: 10.1371/journal.pone.0080268.g005
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vivo  [34].  Mineralocorticoids  (DOCA)  and  angiotensin-II  are
known  as  potent  inducers  of  high  blood  pressure  leading  to
cardiac remodelling and hypertrophy [35,36]. The higher level
of cardiac fibrosis in response to DOCA or angiotensin-II may
appear  to  contradict  the  increased  level  of  Col3a  gene
expression and scar formation in the absence of SGK1 after
cardiac infarct. However, the cross-talk between SGK1 and the
downstream  signalling  pathways  activated  in  myocardial
ischemia  and  hypertension,  respectively,  likely  lead  to
disparate outcomes.
In  summary,  SGK1  is  an  important  player  in  angiogenic
processes  of  the  heart  after  injury.  Our  analysis  of
perturbations in relevant downstream signalling pathways in its
Figure 6.  Effect of SGK1 ablation on cardiac collagen deposition after LAD injury.  (A) Gene expression analysis of Col3a in
WT and SGK1-/- heart one month after LAD. One-way ANOVA has been used to analyse significance among groups. * Indicates
p<0.05 and n was ≥4 in each group. (B) Histological analysis of LAD operated hearts from WT and SGK1-/- mice one month after
operation. Hearts were stained for the collagen marker, picro-sirius red. Epicardial and endocardial scar size was quantified in 3
different hearts in both WT and SGK1-/- and the mean value is the results of 10 distinct microscope field analysed in each group.
Scale bars represent 1mm. Student t-test has been used to calculate p-value and * indicates p<0.05 (B). The data are reported as
Mean ± SE.
doi: 10.1371/journal.pone.0080268.g006
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cardiac  pathology  representing  potential  therapeutical  and
pharmacological  targets  in  cardiac  repair  and  regeneration
studies.
Conclusion
Our collective findings establish a link between SGK1 and
cardiac neo-angiogenesis, shedding new light on the signalling
pathways  implicated  in  physiologic  and  pathologic  vessel
formation.
Supporting Information
Figure S1.  SGK2 and SGK3 protein expression in the WT
and SGK1-/- hearts. Western blot analysis of SGK2 and SGK3
protein  expression  in  heart  extracts  from  WT  and  SGK1-/-
mice. GAPDH was used as loading control. Quantification of
band  intensities  was  performed  using  imageJ.  N=4  in  each
group.  Student  t-test  showed  no  significant  (ns)  differences
between WT and SGK1-/-. The data are reported as Mean ±
SE.
(TIF)
Figure  S2.    VEGF  expression  in  cardiac  cells  and  tube
formation analysis of ECs from WT and SGK1-/- hearts in
Figure 7.  Reduced vessel density around the scar in SGK1-/- hearts.  Microvessel density was measured in sham operated (A)
and in LAD hearts (B). Microvessels were stained with biotinylated isolectin beta 4 (ILB4) and cardiomyocytes with WGA. Scale bars
represent 50 µm in sham operated and 20 µm in LAD. The ratio of small vessels per cardiomyocytes (C) and per mm2 (D) is
reported in the graphs. The number of hearts analysed was ≥4 in each group. One-way ANOVA was used to analyse significance
among groups. (E) Measurements of cross-sectional area (CSA) 1 month after infarction in WT and KO mice. The number of hearts
analysed was ≥4 in each group and ten distinct microscope fields for each slide were analysed. Ns, non-significant. ** Indicates
p<0.01, *** p<0.001 and ns, non-significant. The data are reported as Mean ± SE.
doi: 10.1371/journal.pone.0080268.g007
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PLOS ONE | www.plosone.org 11 November 2013 | Volume 8 | Issue 11 | e80268response to neutralizing VEGF-A. Quantification by Image J
(see  Material  and  Methods)  of  western  blot  analysis  for  the
expression  of  VEGF-A  proteins  20  and  25  in  primary
endothelial  cells  (A)  and  cardiomyocytes  (B).  GAPDH  was
used as loading control. The number of hearts used was ≥3 in
each group. The data are reported as Mean ± SE. (C) Primary
ECs  from  WT  and  SGK1-/-  hearts  were  assessed  for  tube
formation  capacity  in  response  to  VEGF-A  neutralizing
antibody (2µg/ml). IgG was used as negative control. ECs were
analysed for tube formation after 7h incubation with or without
VEGF-A or IgG.
(TIF)
Figure  S3.    Proteomic  profile  in  SGK1-/-  and  WT  hearts.
Three  hearts  from  WT  and  SGK1-/-  mice  were  lysed  and
proteins extracted in non-denaturing conditions by using lysis
buffer  from  Kinexus.  Fluorescent-labelled  proteins  were
processed by Kinexus onto a KinexTM 850 antibody microarray
chip. Fluorescent emission upon protein-antibody binding was
detected  and  measured  as  Z-ratio  (emission  amount  in
SGK1-/- over WT). Expression and/or phosphorylation levels of
different  proteins  were  downregulated  (negative  values)  or
upregulated (positive values). Btk, regulator of NFkB activity,
was  upregulated  in  KO  hearts  confirming  our  western  blot
analyses.
(TIF)
Figure S4.  Re-expression of SGK1 rescued tube network
formation in KO ECs. ECs from SGK1-/- hearts were isolated
and  infected  with  an  adenovirus  expressing  the  constitutive
active  form  of  SGK1  (Ad-SGK1  CA-GFP)  and  with  a  control
adenovirus  expressing  beta-galactosidase  (βGal;  Ad  βGal-
GFP).  Both  viruses  co-expressed  green  fluorescent  protein
(GFP), as shown in panels (A) 12 hours after viral infection.
Infected  SGK1-/-  ECs  formed  tube  networks  7  hours  after
plating in matrigel, conversely to ECs infected with control virus
(B). Total cell extracts from Ad-SGK1 CA-GFP and Ad βGal-
GFP infected ECs were analysed for SGK1 expression. Blots
were  normalized  with  alpha-tubulin.  Arrow  indicates  SGK1
expression  in  KO  ECs  infected  with  Ad-SGK1  CA-GFP  or
control virus (C). The reported data have been assessed in two
independent  experiments.  In  each  independent  experiment,
three separate analyses were performed.
(TIF)
Figure  S5.    Isolectin  beta  4  staining  of  vessels.
Microvessels were stained in WT (A) and SGK1-/- hearts (B)
with biotinylated isolectin beta 4 (ILB4). Nuclei were visualized
with  DAPI  staining.  Scale  bars  represent  50µm  and  arrows
point to small vessels.
(TIF)
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